Similar articles

• Defective monocyte function in patients with genitourinary carcinoma.

  Hausman MS, Brosman S, Snyderman R, Mickey MR, Fahey J. Hausman MS, et al. J Natl Cancer Inst. 1975 Nov;55(5):1047-54. doi: 10.1093/jnci/55.5.1047. J Natl Cancer Inst. 1975. PMID: 1107568
• Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test.

  Bean MA, Pees H, FOGH JE, Grabstald H, Oettgen HF. Bean MA, et al. Int J Cancer. 1974 Aug 15;14(2):186-97. doi: 10.1002/ijc.2910140207. Int J Cancer. 1974. PMID: 4477555 No abstract available.
• Correlation among host immunocompetence and tumor stage, tumor grade and vascular permeation in transitional carcinoma.

  Catalona WJ, Chretien PB. Catalona WJ, et al. J Urol. 1973 Nov;110(5):526-8. doi: 10.1016/s0022-5347(17)60270-2. J Urol. 1973. PMID: 4750895 No abstract available.
• Immunologic features of genitourinary cancer.

  Javadpour N. Javadpour N. Urology. 1973 Aug;2(2):103-8. doi: 10.1016/0090-4295(73)90239-2. Urology. 1973. PMID: 4129366 Review. No abstract available.
• Quantitative light microscopy in urological oncology.

  van der Poel HG, Schaafsma HE, Vooijs GP, Debruyne FM, Schalken JA. van der Poel HG, et al. J Urol. 1992 Jul;148(1):1-13. doi: 10.1016/s0022-5347(17)36494-7. J Urol. 1992. PMID: 1613843 Review. No abstract available.